Cryptosporidium

If you've had diarrhea that won't quit, picked up something on a trip, or you're managing a weakened immune system, the question is rarely "do I have a stomach bug" but "which one, and what should I do about it." This test answers that question for one of the trickier parasites in the gut, by looking directly for its DNA in your stool.

Cryptosporidium is a microscopic parasite that lives in the surface cells of your intestines and is shed in stool. A PCR (a lab technique that finds and copies tiny amounts of DNA) test for it is the most sensitive widely available way to confirm or rule out infection, and it can tell you something traditional microscopy and rapid antigen tests often cannot.

What This Test Actually Detects

This is a stool PCR (a lab technique that finds and copies tiny amounts of DNA from a sample) for Cryptosporidium parasite DNA. The signal comes from the parasite itself, not from your body. It is shed into stool when the parasite is infecting the surface cells lining your intestines. Common gene targets the lab amplifies include SSU rRNA, COWP, DnaJ, and GP60, which is also used to identify the specific species or subtype.

A positive result means parasite DNA was detected in the sample, which usually reflects current or recent intestinal infection and active shedding. A negative result means no parasite DNA was detected, though no PCR assay achieves perfect accuracy and stool contains substances that can interfere with the reaction.

Why Diarrhea Is the Headline Symptom

Cryptosporidium primarily infects the small bowel lining, with a preference for the lower small intestine (ileum) and colon, and in people with weakened immunity it can involve the entire digestive tract. The most common symptom is profuse watery diarrhea. In otherwise healthy adults, infection is usually self-limited and lasts about two weeks. In people with weakened immunity, it can cause prolonged or life-threatening illness.

In recent studies using PCR and antigen detection, Cryptosporidium has been identified in a meaningful share of children with diarrhea, and is particularly associated with prolonged diarrhea lasting 7 to 14 days and persistent diarrhea lasting 14 days or more. The parasite can also occasionally involve the lungs, the bile duct system, and the pancreas, though stool PCR is interpreted primarily as an intestinal finding.

Risk in People With Weakened Immunity

The strongest case for testing is in people whose immune system cannot easily clear the parasite. In a pooled analysis of HIV and AIDS patients, overall Cryptosporidium prevalence was about 8.69 percent, with higher rates in people who had diarrhea, low CD4 counts (a measure of immune system strength), and were not on antiretroviral therapy.

Kidney transplant recipients are another high-prevalence group. In one French prospective series, kidney transplant recipients had a 7.3 percent Cryptosporidium prevalence, the highest of any subgroup studied. Adult kidney transplant patients are at significantly higher risk than healthy controls in a recent systematic review, and infections can be asymptomatic in this group, which is why both symptomatic and asymptomatic recipients are sometimes screened.

In people with HIV or AIDS, prolonged Cryptosporidium infection has been linked to chronic diarrhea, dehydration, abdominal pain, vomiting, fever, and wasting. The most severe and prolonged disease is concentrated in people with CD4 counts under 100 cells per microliter, the threshold IDSA and NIH guidelines highlight for highest risk, with additional risk factors including no history of antiretroviral therapy, animal contact, and use of well water.

Risk in Young Children

In children, Cryptosporidium is a major and underappreciated cause of diarrhea. In the GEMS study across sub-Saharan Africa and South Asia, Cryptosporidium was significantly associated with both moderate-to-severe and less-severe diarrhea below 24 months of age. Annual incidence of moderate-to-severe diarrhea attributable to the parasite was 3.48 per 100 child-years in African infants and 3.18 per 100 child-years in Asian infants.

In a Vaccine Impact on Diarrhea in Africa cohort, PCR positivity was more than two times higher in the 6 to 11 month age group at 27.9 percent than in infants younger than 6 months at 10.0 percent, and detection was negligible after 3 years of age. Children whose diarrhea was attributed to Cryptosporidium were more often hospitalized, more often required intravenous fluids, more often wasted or very thin at 23.4 percent versus 14.7 percent, and more often had severe acute malnutrition at 7.7 percent versus 2.5 percent compared with PCR-negative cases.

In children, Cryptosporidium has also been associated with malnutrition, growth deficits, and premature death. Symptomatic infection stunts weight gain more than asymptomatic infection, but asymptomatic infection has been reported to be about twice as common, which may contribute to a broader effect on early childhood growth.

How Sensitive PCR Is, In Practice

Across head-to-head studies, stool PCR consistently detects more Cryptosporidium than standard microscopy or rapid antigen tests. In a clinical trial of 511 diarrheal stools, PCR detected 36 positives versus 29 by microscopy, putting microscopy sensitivity at 83.7 percent and specificity at 98.9 percent compared with PCR. In a separate multiplex tandem PCR study of 472 fecal samples, acid-fast microscopy showed only 56 percent sensitivity for Cryptosporidium, while PCR was 100 percent. Performance varies by microscopy technique: immunofluorescence microscopy is much more sensitive than acid-fast staining, with reported sensitivity around 97 percent in one UK comparison, while modified Ziehl-Neelsen acid-fast staining was significantly lower.

Real-world performance also depends on which gene the assay targets. In one comparison, the SSU rRNA target reached 100 percent sensitivity, while the COWP target was less sensitive but more specific. The authors recommended a sensitive SSU rRNA screen followed by a more specific COWP confirmation.

Rapid antigen tests are not interchangeable with PCR. In 596 African children admitted to hospital with diarrhea, a rapid diagnostic test showed only 49.6 percent sensitivity and 92.5 percent specificity compared with composite PCR. A normal rapid test does not reliably rule out infection, especially when symptoms are persistent.

What a Positive Result Does Not Always Mean

A positive PCR does not automatically mean Cryptosporidium is the cause of your symptoms. The test is sensitive enough to pick up low-level shedding from asymptomatic carriage, lingering shedding after an infection has resolved, or DNA from oocysts that are no longer infectious or from a species that does not typically cause human disease.

In a study of infants in Bangladesh, qPCR detected Cryptosporidium DNA in more stools than a rapid antigen test, but many of those extra detections involved another enteric pathogen that was the more likely cause of diarrhea. In multi-pathogen quantitative testing of pediatric diarrhea, 38.9 percent of cases had two or more pathogens detected at the same time.

This is why interpretation should consider symptoms, exposures, immune status, and other testing. A positive PCR can mean active disease, recent infection, or coincidental carriage, and the clinical question is usually which of those fits your situation.

When Results Can Be Misleading

A negative PCR result does not always mean you do not have Cryptosporidium. Shedding is intermittent, and stool itself contains substances that can block the PCR reaction. In one study, formalin-fixed stools dropped PCR sensitivity to about 50 percent compared with fresh stools, so how the sample is collected and preserved matters.

• Intermittent shedding: the parasite is not released into stool at a constant rate, so a single negative sample can miss an early or low-burden infection. Repeat testing is sometimes needed when suspicion is high.
• Assay differences: not all stool PCR panels target the same gene, and Cryptosporidium often shows lower agreement between panels than other gut pathogens. A negative on one assay does not guarantee a negative on another.
• Sample handling: fresh, properly collected stool gives the best yield. Formalin fixation and long storage can lower detection.
• Antibiotics and antiparasitics: medications like nitazoxanide can reduce parasite shedding before testing. A recent treatment course can lower the chance of detection without proving the infection is gone.

What Companion Findings Look Like

Because diarrhea is rarely caused by a single organism, stool PCR for Cryptosporidium is most useful in the context of a broader workup. Multiplex PCR panels can detect Cryptosporidium alongside other gut parasites, bacteria, and viruses. In one comparison, multiplex panels found organisms in 55.4 percent of inflammatory bowel disease flares versus 9.2 percent by conventional testing, and changed management in 20 percent of patients versus 7.6 percent.

In people with HIV, multiplex gastrointestinal pathogen panels delivered results in about 23.4 hours versus 71.4 hours for conventional testing, and identified more viral pathogens and co-infections. If your provider is trying to figure out the cause of persistent diarrhea, asking whether the stool panel actually includes Cryptosporidium PCR is reasonable, because triage rules vary by hospital and lab.

Why One Reading Is Not the Whole Story

This is a presence-or-absence test for an active infection, not a chronic disease marker. The value comes from acting on the result, not from tracking a number over years. If you test during symptoms, a positive result usually points to an active or recently active infection, and a negative result during symptoms argues against Cryptosporidium as the cause but does not prove it absent.

For ongoing or persistent diarrhea, retesting in 1 to 2 weeks if the first test is negative but suspicion remains high is reasonable, especially if symptoms continue. After treatment, follow-up testing has been used in research to track parasite clearance, but PCR can stay positive for weeks while symptoms resolve, so a single post-treatment positive does not necessarily mean treatment failure. In one trial, Cryptosporidium was detected by qPCR in 44 percent of children at 8 weeks after enrollment.

In immunocompromised people with confirmed infection, periodic retesting can help track whether the parasite has been cleared, particularly when immune recovery is part of the management plan.

What an Unexpected Result Should Make You Do

If your PCR is positive and you have diarrhea, the next steps usually involve confirming the species or subtype, looking for co-infections, and addressing dehydration. Multiplex stool panels can clarify whether another organism is also contributing. Species-level information from GP60 sequencing can help identify outbreaks, point to a source like contaminated water or animal exposure, and guide public health follow-up.

If you are immunocompromised, a positive result is more clinically urgent. Workup typically includes evaluating immune status, such as CD4 count for someone living with HIV, reviewing immunosuppressive medications for transplant recipients, and considering whether the infection has spread beyond the intestine. Treatment decisions should be made with an infectious disease or gastroenterology specialist.

If your PCR is negative but symptoms persist, a repeat sample, a broader stool panel, and assessment for non-infectious causes of diarrhea may be appropriate. A negative result during ongoing symptoms is informative, but not the end of the workup.